PRP for Rotator Cuff & Shoulder Pain

Could PRP Help Your Shoulder?

Rotator cuff injuries are among the most common causes of shoulder pain in active adults — and among the most frustrating to treat. Physical therapy helps many patients, but for those with persistent tendinopathy or partial tears that haven’t responded adequately to conservative care, PRP offers a regenerative alternative worth understanding.

The shoulder is a complex joint, and the evidence for PRP differs meaningfully depending on what you have — tendinopathy, a partial tear, or a full-thickness tear. This page presents the evidence for each honestly, including what research supports and where it falls short.

What Is Rotator Cuff Tendinopathy and Why Does It Matter?

The rotator cuff is a group of four tendons that stabilize the shoulder and power its movement. Rotator cuff tendinopathy refers to degeneration and irritation of these tendons — most commonly the supraspinatus — typically caused by overuse, repetitive overhead activity, or age-related wear.

Partial tears involve a portion of the tendon thickness. Full-thickness tears involve a complete disruption of the tendon. Each has a different clinical presentation, treatment algorithm, and response to PRP.

How PRP Works in the Shoulder

A small blood sample is drawn and processed to concentrate the platelets. The resulting platelet-rich plasma is injected directly into the affected tendon or subacromial space under ultrasound guidance for accuracy. Platelets release growth factors and anti-inflammatory signaling proteins that may help:

  • Reduce chronic tendon inflammation
  • Support tendon cell health and tissue repair
  • Slow the progression of degenerative changes
  • Improve pain and functional capacity

PRP does not regenerate a torn tendon to its original state or replace surgical repair when surgery is clearly indicated. It creates a pro-healing environment that supports the tendon’s own repair mechanisms.

What the Evidence Shows — Rotator Cuff Tendinopathy

The case for PRP:

  • A meta-analysis of 30 RCTs including approximately 2,500 participants found PRP significantly reduced pain and improved function in the short to medium term compared to placebo and corticosteroids
  • Multiple RCTs demonstrate PRP produces superior pain and functional outcomes to corticosteroid injections at 3 and 6 months — the window where PRP’s regenerative effects appear to peak
  • A meta-analysis found a significant difference in favor of PRP at 12 months post-injection, suggesting benefits may build gradually over time rather than peak immediately
  • PRP does not carry the tissue-weakening effects associated with repeated corticosteroid injections — a meaningful advantage for patients requiring ongoing management of a degenerative condition
  • Combining PRP with hyaluronic acid (HA) has shown superior short-term outcomes compared to either treatment alone for partial rotator cuff tears

The case for caution:

  • Long-term benefits beyond 12 months appear limited in some studies, with outcomes converging with control groups — suggesting PRP may serve as a catalyst for healing rather than a permanent solution
  • No significant differences in pain were observed between PRP and corticosteroids at 6 weeks or 12 months in several studies, suggesting timing of outcome measurement significantly influences conclusions
  • Overall functional improvement in some systematic reviews was better with control treatments than PRP, even when pain scores favored PRP — pain and function do not always move together
  • Significant heterogeneity exists across studies in PRP preparation, platelet concentration, injection technique, and delivery location — making direct comparison difficult and protocols non-interchangeable

What the Evidence Shows — Partial-Thickness Rotator Cuff Tears

The case for PRP:

  • A meta-analysis of 12 studies involving 762 patients found PRP effective in reducing pain for partial-thickness rotator cuff tears in both the short and longer term
  • A systematic review found PRP associated with significant improvement in pain scores at 6 weeks, 3 months, 6 months, and 1 year compared to saline, corticosteroids, dry needling, and physical therapy
  • A single subacromial PRP injection was found effective in improving pain and function significantly at 3 and 6 months in patients with tendinopathy refractory to conservative treatment
  • Multiple injections are associated with better long-term pain outcomes compared to a single injection

The case for caution:

  • Impact on functional recovery appears constrained and does not consistently endure over time
  • Significant heterogeneity in study design, PRP composition, and delivery location limits the strength of conclusions
  • Evidence remains mixed — some well-designed trials show no significant benefit over control

What the Evidence Shows — Full-Thickness Tears and Post-Surgical Augmentation

The case for PRP:

  • Leukocyte-poor PRP augmentation to arthroscopic rotator cuff repair has been shown to significantly reduce retear rates compared to surgery alone in tears under 3 cm
  • A systematic review and meta-analysis of 21 RCTs found PRP augmentation to surgery decreased retears and improved pain and functional scores including Constant-Murley and VAS scores

The case for caution:

  • Despite reduced retear rates, functional outcome scores did not significantly differ between PRP-augmented and non-augmented repair groups in some studies — structural integrity and clinical function do not always correlate
  • For large or irreparable full-thickness tears, PRP alone is generally not appropriate and surgical evaluation is necessary

What This Means for Patient Selection

PRP for the shoulder is most appropriate when:

  • Rotator cuff tendinopathy has persisted despite physical therapy and anti-inflammatory treatment
  • Prior corticosteroid injections provided only temporary relief or are no longer appropriate due to concerns about repeated steroid use
  • Partial-thickness tears are present and surgical repair is not immediately indicated
  • The patient is looking for a more biologically active, potentially more durable alternative to ongoing steroid injections
  • As a surgical adjunct — PRP augmentation to rotator cuff repair may reduce retear rates in smaller tears

PRP is generally not recommended for:

  • Large or full-thickness rotator cuff tears where surgical repair is the primary treatment
  • Cases with significant structural failure requiring immediate surgical intervention
  • Patients with active infection, malignancy, bleeding disorders, or other contraindications

Before Your Procedure

Avoid NSAIDs (such as ibuprofen, Mobic, naproxen, or Celebrex) for at least one week before and one week after your PRP injection. NSAIDs directly counteract the inflammatory signaling that drives PRP’s effectiveness.

What to Expect

The procedure is performed in-office under ultrasound guidance. A small blood sample is drawn, processed on-site, and injected into the affected tendon or subacromial space. The procedure typically takes under an hour.

Most patients return to light activity the same day, with mild soreness at the injection site common for several days. Improvements develop gradually — most patients notice meaningful changes within two to six weeks, with continued gains possible over several months. Some patients benefit from a series of injections.

From a Research & Clinical Perspective

The evidence for PRP in rotator cuff tendinopathy and partial tears supports its use as a short to medium-term intervention — particularly for patients with persistent pain who have not responded adequately to conservative care or who are experiencing diminishing returns from repeated corticosteroid injections. Long-term benefits beyond 12 months are less consistent, and not all studies demonstrate superiority over control treatments. Preparation quality, injection location, and number of injections appear to significantly influence outcomes. Dr. Murakami will review the current evidence alongside her clinical experience to discuss whether PRP is an appropriate option for your specific shoulder presentation.

Sources & Further Reading

The following peer-reviewed studies informed the content on this page. Links open in a new tab.

Supporting Evidence

  • Rout R, et al. (2025). The Effectiveness of Platelet-Rich Plasma in the Management of Rotator Cuff Tears: A Systematic Review and Meta-Analysis. Cureus.
  • Singh J, et al. (2025). Effectiveness of PRP in Treating Rotator Cuff Tendinopathy: A Systematic Review and Meta-Analysis. Journal of Orthopaedic Case Reports. (30 RCTs, ~2,500 participants — significant short-term pain and function improvements.)
  • Desouza C, Shetty V. (2024). Effectiveness of PRP in Partial-Thickness Rotator Cuff Tears: A Systematic Review. Journal of ISAKOS. (12 studies, 762 patients — PRP effective for pain reduction short and long term.)
  • Rossi LA, et al. (2021). Subacromial PRP Injections Decrease Pain and Improve Functional Outcomes in Patients with Refractory Rotator Cuff Tendinopathy. Arthroscopy.
  • Rossi LA, et al. (2024). Leukocyte-Poor PRP as Adjuvant to Arthroscopic Rotator Cuff Repair Reduces Retear Rate but Does Not Improve Functional Outcomes: A Double-Blind RCT. American Journal of Sports Medicine.
  • Weninger V, et al. (2025). Hyaluronate Acid Plus PRP Is Superior to Steroids for Pain Relief Less Than 6 Months Using Injection Therapy of Partial Rotator Cuff Tears: A Systematic Review and Network Meta-Analysis. Arthroscopy.

Negative and Limiting Evidence

Clinical Practice Guidelines

This page was last reviewed March 2026.

PRP for Shoulder Consultation